Trial intelligence / Profile preview

Hydrocortisone Acetate Suppositories in Internal Hemorrhoids

NCT03335774Phase 2Completed

Sponsor
Nivagen Pharmaceuticals
Start
Feb 2019
Primary completion
Mar 2021
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of hydrocortisone in internal hemorrhoids, sponsored by Nivagen Pharmaceuticals. Started Feb 2019; status: completed.

02

Drugs

hydrocortisone
03

Conditions

internal hemorrhoids

Beyond the preview

Go deeper on NCT03335774.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03335774.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call